Kalaris Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kalaris Therapeutics Inc
CIK #0001754068
EDGAR Form CIK 2011 - 2026
10-K [0001754068]
10-Q [0001754068]
3 [0001754068]
4 [0001754068]
5 [0001754068]
8-K [0001754068]
D [0001754068]
SC 13D [0001754068]
SC 13G [0001754068]
Form 13D/13G Filer Form 13D/13G Subject Filed
RTW Investments LP Kalaris Therapeutics Inc [2026-02-17]
Samsara Biocapital LP Kalaris Therapeutics Inc [2025-03-25]
Octagon Capital Advisors LP Allovir Inc [2024-10-11]
EcoR1 Capital LLC Allovir Inc [2024-02-01]
Wilson John Robert Allovir Inc [2024-01-09]
Gilead Sciences Inc Allovir Inc [2022-08-08]
Globeways Holdings II Ltd Allovir Inc [2022-08-05]
Artal International SCA Allovir Inc [2022-08-05]
Globeways Holdings II Ltd Allovir Inc [2020-08-13]
Elevatebio LLC Allovir Inc [2020-08-13]
FMR LLC Allovir Inc [2020-08-10]
Form 3/4/5 Subject 2011 - 2026
Akkaraju Srinivas
Kalaris Therapeutics Inc
Hallal David
Dybbs Michael
Patterson Leone D
Adamis Anthony P
Jovan-Embiricos Morana
Ferrara Napoleone
Samsara BioCapital LP
Samsara Opportunity Fund GP LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kalaris Therapeutics Inc KLRS
Common Stock
2026-03-20 Sell 1,915 $6.72 12,869
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 222,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 95,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 135,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 60,800 $0.00
Kalaris Therapeutics Inc KLRS
Common Stock
2025-12-22 Grant 1,500,000 $10.00 15,000,000
Kalaris Therapeutics Inc KLRS
Common Stock
2025-12-18 Buy 479,847 $10.42 5,000,006
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-11-03 Grant 235,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 50,262 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 70,551 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 287,000 $0.00
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 101,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com